FRIDAY, JULY 21, 2017

Dengue-fever test vaccine shows promise in early clinical trials

A team of scientists at the University of Vermont (UVM) Vaccine Testing Center has been working to develop an efficient, single-dose vaccine designed to protect people from the four strains of dengue fever, and the team said this week that clinical trials on a test vaccine have been promising so far. Read More »

Scientists find simpler way to treat malaria

A team of chemists from the King Abdullah University of Science and Technology (KAUST) recently developed a new, simpler way to treat malaria with three powerful chemical groups in a single drug. Read More »

Stanford chemists find ultra-sensitive test for HIV, cancer

A team of chemists from Stanford recently discovered a new, ultra-sensitive test that can detect cancer or HIV infections, suggesting that the test is significantly more sensitive than current technologies. Read More »

U.K. Parliament holds first Evidence Session on meningitis B vaccine petition

The Meningitis Research Foundation (MRF) has commented on the inspiring, moving evidence that was presented at the first Evidence Session at the House of Commons about the upcoming parliamentary debate on a petition to require all people who live in the U,K, and who are under 11 years old, to receive the vaccine for meningitis B, or MenB. Read More »

Human challenge study to accelerate dengue vaccine development

Researchers recently conducted a controlled human challenge study that suggests an experimental dengue vaccine can give healthy volunteers full protection, urging experts to use this evidence to accelerate the development of a dengue vaccine. Read More »

No additional risk for surgical patients receiving influenza vaccine

A recent study suggests that there is no additional risk to surgical patients when they receive the seasonal influenza vaccine while they are still staying at the hospital. Read More »

First unmanned aerial vehicle to diagnose HIV in infants tested in Malawi

The Government of Malawi and UNICEF recently ran the initial test for the first Unmanned Aerial Vehicles (UAVs, commonly called drones) that may be used to decrease the waiting times to test infants for HIV infections. Read More »

All study subjects protected with experimental dengue vaccine

All of the subjects who participated in a clinical trial for an experimental dengue virus vaccine showed vastly different results, as the 21 vaccine recipients did not develop the dengue infection, but the 20 placebo recipients did contract the infection. Read More »

New nano biosensor to quickly detect influenza

A team of scientists have developed a new nano biosensor that is able to quickly detect the influenza and similar viruses with its upconversion luminescence resonance energy transfer (LRET), which is an optical approach. Read More »

'Quantum dots' may lead to new Ebola and HIV treatments

A team of researchers from the University of Leeds recently discovered the method that HIV and Ebola viruses use to bond to cells and spread throughout the body, potentially leading a new way to treat Ebola and HIV infections. Read More »

Liverpool researchers assess alternative malaria prevention measures

Scientists at the Liverpool School of Tropical Medicine have collaborated with the Kenya Medical Research Institute, the Centers for Disease Control and Prevention, and the London School of Hygiene and Tropical Medicine recently conducted a study to find alternative preventatives to malaria for pregnant women living in Kenya. Read More »

Temple researchers erase HIV-1 from human T-cells

Scientists from Temple University's Lewis Katz School of Medicine recently developed a specialized gene editing system that can erase HIV-1 from human T-cells, potentially making a cure for patients with HIV infections. Read More »

Computerized methods support fight against Zika virus

Scientists have developed computer-assisted methods to fight the spread of the Zika virus, which does not have any treatment or vaccine to prevent the disease's transmission. Read More »

Measles, pertussis outbreaks may correlate with vaccination declinations

A recent analysis suggests that intentionally unvaccinated or undervaccinated people may correlate with the measles cases and certain pertussis outbreaks, as turning down vaccines showed a connection with a higher risk for developing the two diseases. Read More »

Only 2 percent of DR-TB patients can access new treatments.

Doctors Without Borders released a new publication of DR-TB Drugs Under the Microscope, showing that just 2 percent out of the 150,000 people with drug-resistant tuberculosis have access to the new, better treatments for the disease. Read More »

Antibodies may eliminate HIV-like virus after exposure

Scientists recently administered antibodies to infant macaques after they had exposure to a virus similar to HIV, with the antibodies effectively eliminating the infection. Read More »

Chimpanzee parasite genomes show human malaria is evolving

An international team of scientists has implemented a selective amplification technique that allowed them to sequence genomes from two species of parasites in chimpanzees, helping them to better understand how human malaria has evolved over time. Read More »

WHO reminds of global goals on World TB Day

The World Health Organization (WHO) is commemorating World TB Day on Thursday by encouraging nations and collaborators to “Unite to End Tuberculosis” from being on the world health scene. Read More »

Long-acting injectable effective against vaginal HIV transmissions

Scientists from the University of North Carolina School of Medicine have conducted a study to show that long-lasting injections containing an HIV drug provide people with protection against HIV transmissions. Read More »

UK charities seek acceptance of meningitis B vaccination plan

Leaders from Meningitis Now and the Meningitis Research Foundation, two U.K. charities dedicated to fighting meningitis, recently said they intend to encourage Petitions and Health committees to accept an action plan against meningitis B. Read More »